ly-367,265 ly-367,265 ly-367,265 is a drug developed by eli lilly, which acts as both a potent and selective antagonist at the serotonin 5-ht2a receptor, and also a selective serotonin reuptake inhibitor (ssri). it has antidepressant effects in animal studies, reduces glutamate signalling in the brain and increases the analgesic effects of morphine. ly-367,265identifiers iupac name 1-(2-(4-(6-fluoro-1h-indol-3-yl)-5,6-dihydropyridin-1(2h)-yl)ethyl)-1,4,5,6-tetrahydro-thiadiazoloquinoline 2,2-dioxide cas number210751-39-6pubchem cid4605800chemspider3797242uniiss58uxz8zuchebichebi:183634chemical and physical dataformulac24h25fn4o2smolar mass452.55 g·mol−13d model (jsmol)interactive image smiles fc1=cc=c2c(nc=c2c3=ccn(ccn(s4(=o)=o)c5=c6c(cccn46)=cc=c5)cc3)=c1 inchi inchi=1s/c24h25fn4o2s/c25-19-6-7-20-21(16-26-22(20)15-19)17-8-11-27(12-9-17)13-14-28-23-5-1-3-18-4-2-10-29(24(18)23)32(28,30)31/h1,3,5-8,15-16,26h,2,4,9-14h2key:bjipvhlrwsdkos-uhfffaoysa-n